ReleaseWire Connect

"Pharmaceutical Lifecycle Management Strategies in 2017" provides a comprehensive assessment of product lifecycle (LCM) management strategies that are being implemented by pharmaceutical companies around the world. The pharmaceutical industry remains highly competitive and lucrative, and companies are investing significant time and resources into implementing strategies aimed at preserving the revenue streams of their products by extending patent life, delaying competition or slowing the pace of revenue loss following the end of market exclusivity.

Hypercalcemia is a condition in which the calcium level in the blood is above normal. Too much calcium in the blood can weaken the bones, create stones in the kidneys, and interfere with the functioning of the heart and the brain. Hypercalcemia refers to the condition where too much calcium enters the extracellular fluid or when there is insufficient calcium excretion from the kidneys. The cases of hypercalcemia are mainly caused by malignancy or hyperparathyroidism. Hypercalcemia is an outcome of overactive parathyroid glands. These four tiny glands are located near thyroid gland and each of them are about the size of a rice grain.

Therapeutic drug monitoring is a branch of clinical pharmacology and clinical chemistry that specializes in the measurement of drug concentration in blood. It is mainly performed on the drugs with a narrow therapeutic window. Therapeutic drug monitoring aims at improving patient care by regulating the dose of drugs. It is based on a priori pharmacogenetic, demographic, and clinical information. It also considers a posteriori measurement of drug concentration in the blood.

Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design" provides an in-depth assessment of the current trends in the global biosimilars market, with a particular focus on manufacturing complexities and the strategies being implemented to overcome them. This report also assesses the state of the biosimilar R&D and commercial landscape through multilevel analytics that include data split by therapy area, stage of development, molecular target, clinical trials and company. Global revenue forecasts to 2022 for biosimilars with strong market potential, both in development and in the market, are provided.

Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing" provides a comprehensive analysis of the changing pharmaceutical marketing landscape in the digital age.

HCM is the enlargement of the heart muscle (myocardium), which disrupts the functions of the heart. HCM is mostly caused due to gene mutation and is a significant cause of sudden cardiac death in any age group. Hypertrophy is defined as an enlargement of a tissue or organ, and cardiomyopathy refers to diseases related to heart muscles. Therefore, HCM is defined as a condition, which is characterized by abnormal thickening of heart muscles, which makes pumping of blood from the heart to various organs difficult. Therefore, the heart must induce more pressure to pump blood to various vital organs.

This market's value is expected to continuing growing, especially within the resorbable segment. The resorbable market maintained the clear majority due to its clear advantages despite its higher price point. The resorbable market is highly attractive in terms of its potential for revenues, therefore drawing in a number of competitors. Growth in unit sales will continue to push this market's value forward. Despite the dominance of resorbable products, the non-resorbable market continues to exhibit growth. Non-resorbable qualities are attractive in specific cases, with most of their appeal stemming from its relatively inexpensive price point. The bulk of non-resorbable membranes are titanium-based, which is available at a much less expensive price than alternative materials. The combination of the weak economy in Brazil and lack of government insurance makes the region a cost-sensitive environment. As such, relatively inexpensive products are an especially important option in the dental market. Nonetheless, the benefits associated with resorbable products have shrunk the market for non-resorbable materials. Overall, non-resorbable products will remain relevant as a cost-efficient solution, but will continually represent the minority in the dental membrane market.

According to a NHS report of July 2015, eight out of ten women are diagnosed with breast cancer in the UK and survive for minimum five years post diagnosis. Lumpectomy, a type of breast-conserving therapy for treating breast cancer, has emerged in the European market, owing to the presence of innovative technologies. Intraoperative surgical margin, sentinel lymph node biopsy assessment systems, and surgical tools are some of the technical devices used in the treatment of lumpectomy.

The technological advancements have led to the introduction of innovative in-the-ear products in the market. The battery operated conventional devices have been replaced by advanced, wireless hearing aid devices. The rise in the prevalent cases of hearing loss and transition in the demographics has contributed to the increased use of hearing aids. However, the market faces challenges with the poor reimbursement policies and patient discomfort with the hearing aids.

Snoring is the vibration of the respiratory channel in the human body that results in the generation of sound due to obstructed air movement during breathing in the sleep. In some of the cases, the sound may be soft, but in some cases, the sound could be loud and unpleasant. Snoring during sleep may be a first alarm of obstructive sleep apnea (OSA). The research study suggests that snoring is one of the factors of sleep deprivation.